Placement Announced

Processa Pharmaceuticals placement

US$200m raised

Announced 29 Jul 2026 · NASDAQ: PCSA · US$1221.19 cash per share

Advisers

Processa Pharmaceuticals

Issuer

Not disclosed

Lead managers

Legal adviser
Placement agent
UBS (co)
Issuer
Processa Pharmaceuticals
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.